Jefferies analysts have noted that Puig's current valuation represents an 'attractive entry point'. The Ibex company will publish its results on October 21, generating expectations in the market.
Jefferies analysts have reiterated their confidence in Puig, stating that the current valuation of the Ibex company represents an 'attractive entry point'. The information, reported by expansion.com, highlights that Puig's third-quarter results for 2026 will be published on October 21.
A 5% growth in Puig's comparable sales is expected during this period, exceeding the market consensus of 4.9%. This increase also raises the estimated comparable growth for the entire fiscal year 2026 to 4.0%.
The expected growth is attributed to the strong performance of the Charlotte Tilbury brand, which has maintained solid performance in the makeup category. Jefferies notes that this growth offsets the more moderate performance in fragrances and the weakness in prestige skincare.
In the context of the beauty sector, Puig's recent acquisition of the remaining 50% of Isdin is considered timely, given the strong growth in the dermocosmetic segment. This purchase allows Puig to increase its exposure in a high-demand area, while prestige skincare shows more contained behaviour.
Jefferies maintains its recommendation to buy Puig shares and sets a target price of 21 euros per share, representing an upside potential of 24% compared to its previous close of 16.91 euros.
Puig's upward trajectory has allowed it to recover part of the -16% decline it suffered last year, becoming one of the most highly valued stocks on the Ibex. According to LSEG data, of the 18 firms analysing Puig, twelve recommend buying and six suggest holding the investment, with an average target price of 19.04 euros.
You may also like
